文献速递甲状腺核医学核素与放射性配体治疗

自主性甲状腺结节患者接受放射性碘治疗后的长期随访

Long-Term Follow-up of Patients With Autonomous Thyroid Nodules Treated With Radioiodine.
PubMed 文献 · Clin Nucl Med · 2024-04-12

该研究回顾性分析了1997至2017年间在单中心接受放射性碘治疗的165例成人毒性结节性甲状腺肿患者的病历,发现单次放射性碘治疗有效率超过90%,平均放射性碘活度为28.9 ± 3.4 mCi,甲亢缓解平均时间为3.6 ± 3.0个月(范围1-12个月)。治疗后第一年,33.9%的患者出现甲状腺功能减退,59.4%为甲状腺功能正常,6.7%仍为甲状腺功能亢进;20年随访期间甲状腺功能减退的累积发生率为48.9%。治疗失败主要见于接受较低剂量放射性碘治疗的多结节性甲状腺肿较大患者,而进展为甲状腺功能减退主要见于较年轻、甲状腺肿较大且为单结节的患者。

要点

  • 单次放射性碘治疗毒性结节性甲状腺肿的有效率超过90%。
  • 治疗后第一年甲状腺功能减退、正常和亢进的比例分别为33.9%、59.4%和6.7%。
  • 20年随访期间甲状腺功能减退的累积发生率为48.9%。

核心结论

  • 放射性碘治疗是有效且安全的治疗方法。
  • 在Plummer病中,放射性碘治疗后预期可获得较高的甲状腺功能正常率。
  • 治疗失败主要见于接受较低剂量放射性碘治疗的较大多结节性甲状腺肿患者。
  • 进展为甲状腺功能减退主要见于较年轻、甲状腺肿较大且为单结节的患者。

研究设计与样本

  • 回顾性分析1997年至2017年间在单中心甲状腺中心接受放射性碘治疗的165例成人毒性结节性甲状腺肿患者的病历资料。

主要发现

  • 单次放射性碘治疗的有效率超过90%。
  • 平均放射性碘活度为28.9 ± 3.4 mCi。
  • 放射性碘治疗至甲状腺功能亢进缓解的平均时间为3.6 ± 3.0个月,范围为1-12个月。
  • 治疗后第一年,33.9%的患者为甲状腺功能减退,59.4%为甲状腺功能正常,6.7%为甲状腺功能亢进。
  • 在无应答者中,显示统计学差异的变量为多结节性甲状腺肿的存在和放射性碘活度(均值25.5 ± 6.5 mCi;中位数30 [15-30 mCi])。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This article aims to describe the presentation of Plummer disease and its evolution after radioiodine treatment and determine factors that may influence treatment efficacy. PATIENTS AND METHODS: The sample included retrospective medical records of 165 adult patients with toxic nodular goiter treated with radioiodine between 1997 and 2017, followed up at a single thyroid center. RESULTS: The efficacy of treatment with a single dose of radioiodine was higher than 90%. The mean radioiodine activity was 28.9 ± 3.4 mCi. The mean time between radioiodine performance and hyperthyroidism resolution was 3.6 ± 3.0 months, ranging from 1-12 months. After the first year, 33.9% of the patients were under hypothyroidism, 59.4% under euthyroidism, and 6.7% under hyperthyroidism. Among the nonresponders, the variables that showed statistical difference were the presence of multinodular goiter and the radioiodine activity (mean, 25.5 ± 6.5 mCi; median, 30 [15-30 mCi]). The cumulative rate of hypothyroidism was 48.9% over 20 years of follow-up. CONCLUSIONS: Radioiodine therapy is an effective and safe treatment. In Plummer disease, high rates of euthyroidism are expected after the radioiodine treatment. Therapeutic failure was observed mainly in patients with larger multinodular goiters treated with lower doses of radioiodine. The evolution to hypothyroidism was mostly observed in younger patients with larger and uninodular goiters.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Moroto D, Torquato-Vieira ICO, Fiorin LB, et al. Long-Term Follow-up of Patients With Autonomous Thyroid Nodules Treated With Radioiodine. Clin Nucl Med. 2024. PMID: 38619976. doi:10.1097/RLU.0000000000005189

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。